LOGO.png
GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy
27 févr. 2024 07h45 HE | The Greater Cannabis Company, Inc.
BALTIMORE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation...
LOGO.png
GCANRx Featured in American Journal of Endocannabinoid Medicine
21 sept. 2023 08h29 HE | The Greater Cannabis Company, Inc.
BALTIMORE, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next...
LOGO.png
GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders
05 juil. 2023 08h33 HE | The Greater Cannabis Company, Inc.
BALTIMORE, July 05, 2023 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next...
LOGO.png
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
07 oct. 2022 09h20 HE | The Greater Cannabis Company, Inc.
BALTIMORE, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid...
weed.6
GCANRx Strategic Advisor Dr. Adi Aran to be Interviewed by Dr. Sanjay Gupta on CNN Cannabis Special
16 déc. 2021 09h35 HE | The Greater Cannabis Company, Inc.
The 6th Installment in the Award-winning Series by Dr. Sanjay Gupta will Air on Sunday, December 19th at 9pm ET BALTIMORE, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc....
LOGO.png
GCANRx Appoints Renowned Cannabinoid Researcher Dr. Adi Aran as Strategic Advisor
02 déc. 2021 08h52 HE | The Greater Cannabis Company, Inc.
Dr. Aran will be focused on furthering development of the therapeutic pipeline, advancing the clinical study program and supporting IP and regulatory strategies. BALTIMORE, Dec. 02, 2021 (GLOBE...